Skip to main content

Table 3 External validation of model 4

From: In silico studies of some 2-anilinopyrimidine derivatives as anti-triple-negative breast cancer agents

Name

pIC50

VR1_Dzv

SpMin1_Bhs

C3SP3

MOMIR

Ypred

YpredYobs

26

4.06

695.2029

1.8450

0

9.5814

4.1940

− 0.1340

4

4.06

505.8137

1.8685

0

10.1391

4.1625

− 0.1025

2

4.07

507.3869

1.7777

0

9.7376

4.1063

− 0.0364

8

4.09

1589.825

1.8089

0

10.0072

4.0429

0.0471

12

4.35

507.0445

1.8648

0

9.7426

4.2090

0.1409

13

4.29

1135.849

1.8954

1

9.5861

4.6054

− 0.3154

23

4.44

723.6867

1.8626

0

9.6193

4.2091

0.2308

30

4.77

461.2732

1.9174

1

9.7076

4.6569

0.1131

25

4.1

650.2583

1.7925

0

9.3087

4.1705

− 0.0704